Connect with us

Press Releases

Drug Company Opens US Office to Serve Eyecare Market

mm

Published

on

It formed a subsidiary in MA.

HEIDELBERG, GERMANY — Novaliq GmbH has formed a subsidiary called Novaliq Inc. in Cambridge, MA.

Novaliq GmbH describes itself as “a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology.”

The Cambridge office will be headed by Novaliq’s founder and current chief innovation officer, Bernhard Günther. Günther “ill build the new U.S. organization to leverage the advantages and the potential of the water-free EyeSol drug delivery technology and innovative products in the U.S.,” according to a press release.

“Over the past two years, Novaliq has gained significant momentum,” Günther said. “With the opening of our new U.S. subsidiary, we can better serve the important and growing U.S. eyecare market. I am excited to take on this new challenge and to lead the internationalization of the Novaliq group.”

Advertisement

In the U.S., Novaliq is currently pursuing two late-stage clinical trials in ophthalmology: one for topical CyclASol for the treatment of dry eye disease (DED), and the other to evaluate a compound called NOV03 at two different dosing regimens for evaporative dry eye disease.

“As a leader in DED with first and best-in-class products, we see our role in redefining how this disease is treated,” said Christian Roesky, CEO of Novaliq GmbH. “In the U.S., more than 16 million patients are diagnosed with DED; however, only approximately 10 percent are being treated. This significant gap is a clear indication that new DED therapies are needed. A strong presence in the United States will assist us to better serve this vital pharma market.”

SPONSORED VIDEO

See What’s Possible with EssilorLuxottica 360

When you have 360 degrees of support, you can grow your independent practice with confidence. When that support comes from industry leaders with a proven track record of providing partnership opportunities which help independent practices maximize their success – well, the possibilities are endless. From increased visibility through cutting-edge marketing to enhanced patient experiences leading to a better capture rate and everything in between, see what’s possible with EssilorLuxottica 360. Learn more at 360.EssilorLuxottica.com. Powering your practice. Empowering you.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular